0001437749-21-000725.txt : 20210114 0001437749-21-000725.hdr.sgml : 20210114 20210114163514 ACCESSION NUMBER: 0001437749-21-000725 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210113 FILED AS OF DATE: 20210114 DATE AS OF CHANGE: 20210114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bruck Claudine CENTRAL INDEX KEY: 0001733680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 21529132 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVE, SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017-3552 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 rdgdoc.xml FORM 4 X0306 4 2021-01-13 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001733680 Bruck Claudine 4995 BRADENTON AVE., SUITE 240 DUBLIN OH 43017 1 Common Stock 2021-01-13 4 A 0 2500 0.001 A 12550 D Stock Option 2.28 2021-01-13 4 A 0 2500 0.001 A 2022-01-13 2031-01-13 Common Stock 2500 2500 D Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant. /s/ Jed A. Latkin for Claudine Bruck, by power of attorney 2021-01-14